Jennifer Chien
Corporate Officer/Principal bij RHYTHM PHARMACEUTICALS, INC.
Vermogen: 296 897 $ op 31-03-2024
Profiel
Jennifer L.
Chien is currently the Executive Vice President & Head-North America at Rhythm Pharmaceuticals, Inc. Prior to this, she worked as the Vice President & Head-Genetic Diseases at Genzyme Therapeutics Ltd.
from 2017 to 2020.
She also briefly served as the Chief Commercial Officer at Krystal Biotech, Inc. in 2020.
Ms. Chien received her graduate degree from Harvard University and her undergraduate degree from Massachusetts Institute of Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-03-2024 | 6 852 ( 0.01% ) | 296 897 $ | 31-03-2024 |
Actieve functies van Jennifer Chien
| Bedrijven | Functie | Begin |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 09-11-2020 |
Eerdere bekende functies van Jennifer Chien
| Bedrijven | Functie | Einde |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Corporate Officer/Principal | 16-10-2020 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 01-01-2020 |
Opleiding van Jennifer Chien
| Harvard University | Graduate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| KRYSTAL BIOTECH, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
